EMD Serono, Inc. will open a site in Cambridge, MA to support its growing research activities. The laboratory space will accommodate EMD Serono’s U.S. drug discovery activities in neurodegenerative diseases such as multiple sclerosis (MS), intended to augment the company’s existing U.S. research in oncology and fertility. EMD Serono expects to occupy the site with nearly 50 scientists across disciplines, including neurobiology, pharmacology and chemistry, to work at the location. ...